FokkensWJ, ViskensAS, BackerV, et al.EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023;61(3):194–202.
2.
Suárez-FariñasM, UngarB, NodaS, et al.Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing. J Allergy Clin Immunol. 2015;136(5):1277–1287.
3.
AlotaibiL, AlfawzanA, AlharthiR, et al.Improvement of atopic dermatitis and alopecia universalis with dupilumab. Dermatol Rep. 2021;14(2):9359.
4.
CallJE, SahniS, ZugKA. Effectiveness of dupilumab in the treatment of both atopic dermatitis and alopecia universalis. Clin Case Rep. 2020;8(8):1337–1339.
5.
RomagnuoloM, BarbareschiM, TavecchioS, et al.Remission of alopecia universalis after 1 year of treatment with dupilumab in a patient with severe atopic dermatitis. Skin Appendage Disord. 2022;8(1):38–41.